(2R,4R)-APDC is a selective group II metabotropic glutamate receptors (mGluRs) agonist. It has anticonvulsant and neuroprotective effects.

(2R,4R)-APDC (1-10 nmol; ICV; daily for 14 days) decreases cell proliferation in the dentate gyrus [2].

Animal Model: Adult male Sprague-Dawley rats weighing between 300 and 350 g. Dosage: 1 nmol/10 μl; 10 nmol/10μl. Administration: ICV; daily for 14 days [2]

169209-63-6

C6H10N2O4

174.15

(2R,4R)-APDC

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years